Table 4.
Age-standardised 5-year net survival by cancer site, country and period of diagnosis in patients aged 75 years and older
| Australia* | Canada† | Denmark | Ireland‡ | New Zealand | Norway | UK§ | |
|---|---|---|---|---|---|---|---|
| Oesophagus | |||||||
| 1995–99 | 10·9% (8·9–13·1) | 8·8% (7·0–10·8) | 1·5% (0·4–4·6) | 6·0% (3·6–9·2) | 8·5% (5·2–12·6) | 5·4% (2·8–9·4) | 3·4% (3·0–3·8) |
| 2000–04 | 9·8% (8·1–11·8) | 8·6% (7·0–10·3) | 4·1% (2·4–6·5) | 5·7% (3·7–8·3) | 3·4% (1·8–5·7) | 3·4% (1·6–6·3) | 4·4% (4·0–4·8) |
| 2005–09 | 11·1% (9·4–13·0) | 9·6% (8·1–11·3) | 3·8% (2·2–6·1) | 8·4% (6·0–11·3) | 5·7% (3·7–8·3) | 3·7% (1·8–6·6) | 5·6% (5·1–6·0) |
| 2010–14 | 14·8% (12·3–17·5) | 10·9% (9·0–13·0) | 8·4% (4·9–13·0) | 9·4% (6·4–13·1) | 6·7% (4·2–10·0) | 6·0% (3·0–10·3) | 7·5% (7·0–8·1) |
| Absolute change | 3·9 | 2·1 | 6·9 | 3·4 | −1·8 | 0·6 | 4·1 |
| Stomach | |||||||
| 1995–99 | 17·5% (15·6–19·5) | 17·1% (15·5–18·8) | 8·6% (6·2–11·4) | 11·3% (8·4–14·6) | 16·1% (12·8–19·8) | 15·9% (13·5–18·4) | 8·1% (7·6–8·6) |
| 2000–04 | 19·3% (17·4–21·3) | 17·5% (16·0–19·1) | 9·3% (6·9–12·1) | 12·5% (9·7–15·7) | 15·2% (11·9–18·9) | 14·2% (11·9–16·7) | 9·0% (8·5–9·5) |
| 2005–09 | 20·2% (18·2–22·1) | 20·4% (18·8–22·0) | 8·5% (6·4–11·0) | 11·4% (9·0–14·2) | 16·8% (13·4–20·6) | 17·4% (14·6–20·5) | 9·9% (9·4–10·5) |
| 2010–14 | 21·5% (19·1–24·0) | 22·1% (20·2–24·0) | 14·7% (11·5–18·3) | 17·8% (14·2–21·7) | 13·1% (9·8–16·8) | 18·1% (14·7–21·9) | 12·6% (11·9–13·3) |
| Absolute change | 4·0 | 5·0 | 6·1 | 6·5 | −3·0 | 2·2 | 4·5 |
| Colon | |||||||
| 1995–99 | 53·4% (51·9–54·9) | 55·1% (53·9–56·3) | 46·4% (44·1–48·7) | 44·3% (40·9–47·5) | 59·0% (56·1–61·8) | 50·8% (48·4–53·1) | 38·4% (37·8–39·0) |
| 2000–04 | 56·6% (55·2–57·9) | 56·6% (55·5–57·6) | 51·1% (48·8–53·4) | 45·6% (42·7–48·5) | 58·5% (56·0–61·0) | 52·4% (50·2–54·5) | 41·8% (41·2–42·4) |
| 2005–09 | 60·6% (59·3–61·9) | 59·2% (58·2–60·2) | 50·9% (48·7–53·1) | 48·2% (45·5–50·8) | 58·4% (56·0–60·7) | 57·7% (55·6–59·7) | 45·0% (44·4–45·6) |
| 2010–14 | 64·5% (63·0–66·1) | 59·9% (58·7–61·1) | 64·3% (61·6–66·8) | 50·5% (47·4–53·6) | 56·3% (53·8–58·7) | 60·1% (57·7–62·4) | 46·1% (45·5–46·8) |
| Absolute change | 11·1 | 4·8 | 17·9 | 6·2 | −2·7 | 9·3 | 7·7 |
| Rectum | |||||||
| 1995–99 | 50·8% (48·0–53·4) | 49·7% (47·3–52·0) | 40·3% (36·8–43·8) | 42·6% (37·0–48·1) | 51·0% (45·6–56·2) | 47·2% (43·7–50·6) | 35·1% (34·0–36·1) |
| 2000–04 | 53·8% (51·4–56·2) | 53·0% (50·8–55·1) | 44·5% (40·8–48·0) | 37·4% (32·6–42·2) | 52·0% (47·0–56·8) | 53·2% (49·7–56·6) | 39·5% (38·5–40·5) |
| 2005–09 | 58·6% (56·1–60·9) | 54·6% (52·6–56·6) | 49·1% (45·9–52·3) | 41·5% (37·0–46·0) | 52·2% (47·6–56·6) | 54·9% (51·2–58·4) | 41·7% (40·7–42·7) |
| 2010–14 | 60·7% (57·7–63·5) | 53·4% (51·1–55·6) | 60·7% (56·7–64·5) | 49·4% (43·7–54·9) | 55·7% (50·3–60·7) | 60·9% (56·5–65·0) | 46·2% (45·0–47·3) |
| Absolute change | 9·9 | 3·7 | 20·4 | 6·8 | 4·7 | 13·7 | 11·1 |
| Pancreas | |||||||
| 1995–99 | 3·3% (2·5–4·2) | 4·0% (3·3–4·9) | 2·3% (1·3–3·8) | 3·8% (2·1–6·1) | 5·6% (3·5–8·5) | 2·1% (1·2–3·5) | 1·3% (1·1–1·6) |
| 2000–04 | 3·7% (2·9–4·7) | 3·9% (3·2–4·6) | 1·1% (0·6–2·0) | 4·8% (3·1–7·1) | 4·0% (2·3–6·3) | 2·0% (1·2–3·1) | 1·3% (1·1–1·5) |
| 2005–09 | 3·8% (3·1–4·6) | 5·1% (4·4–5·9) | 1·4% (0·8–2·3) | 4·5% (3·0–6·5) | 2·2% (1·2–3·7) | 3·0% (2·0–4·2) | 1·9% (1·6–2·1) |
| 2010–14 | 6·0% (4·9–7·2) | 3·9% (3·2–4·6) | 3·2% (2·0–4·8) | 4·3% (2·6–6·5) | 1·3% (0·6–2·4) | 4·1% (2·7–5·8) | 2·7% (2·4–3·1) |
| Absolute change | 2·7 | −0·1 | 0·9 | 0·5 | −4·3 | 2·0 | 1·4 |
| Lung | |||||||
| 1995–99 | 7·3% (6·6–8·0) | 10·0% (9·5–10·6) | 3·4% (2·7–4·2) | 5·0% (3·9–6·3) | 7·9% (6·6–9·4) | 4·8% (3·9–5·9) | 3·0% (2·8–3·1) |
| 2000–04 | 9·1% (8·5–9·8) | 10·6% (10·1–11·1) | 4·9% (4·1–5·8) | 4·9% (3·9–5·9) | 6·1% (5·1–7·3) | 5·6% (4·7–6·6) | 3·8% (3·6–4·0) |
| 2005–09 | 10·3% (9·6–10·9) | 11·9% (11·4–12·3) | 6·5% (5·7–7·3) | 6·3% (5·3–7·4) | 6·1% (5·1–7·2) | 7·1% (6·2–8·1) | 4·9% (4·7–5·1) |
| 2010–14 | 13·4% (12·5–14·3) | 14·1% (13·5–14·7) | 12·6% (11·3–13·8) | 10·4% (8·9–12·0) | 7·4% (6·2–8·8) | 11·7% (10·4–13·1) | 7·8% (7·5–8·1) |
| Absolute change | 6·1 | 4·1 | 9·2 | 5·4 | −0·5 | 6·9 | 4·8 |
| Ovary | |||||||
| 1995–99 | 16·4% (13·8–19·2) | 21·6% (19·4–23·9) | 19·0% (15·1–23·3) | 13·7% (9·3–19·0) | 18·4% (13·1–24·3) | 18·8% (14·8–23·2) | 13·7% (12·7–14·6) |
| 2000–04 | 18·2% (15·7–20·9) | 19·6% (17·8–21·6) | 17·5% (14·1–21·2) | 14·9% (10·7–19·7) | 16·0% (11·7–21·1) | 22·1% (18·4–26·0) | 12·9% (12·1–13·8) |
| 2005–09 | 20·9% (18·3–23·7) | 20·6% (18·7–22·5) | 20·4% (16·8–24·2) | 12·0% (8·2–16·5) | 12·8% (8·8–17·6) | 22·0% (18·3–25·9) | 14·8% (14·0–15·7) |
| 2010–14 | 21·8% (18·5–25·2) | 18·9% (16·7–21·1) | 26·2% (21·7–30·9) | 14·3% (10·2–19·1) | 17·5% (12·2–23·5) | 26·5% (21·7–31·6) | 17·7% (16·7–18·9) |
| Absolute change | 5·4 | −2·7 | 7·2 | 0·6 | −0·9 | 7·7 | 4·0 |
Data are 5-year age-standardised net survival estimate (95% CI) and absolute change in percentage points. Absolute change is between 1995–99 and 2010–14.
*
Australia includes New South Wales (1995–2012), Victoria, and Western Australia.
†
Canada includes Alberta, British Columbia, Manitoba, New Brunswick, Nova Scotia, Ontario, Prince Edward Island and Saskatchewan.
‡
Ireland (1995–2013).
§
The UK includes its four consituents countries: England, Scotland, Wales, and Northern Ireland.